NCT00631735

Brief Summary

This study is a qualitative, phenomenological research design. The research question is the lived experience of adult oncology patients undergoing chemotherapy being touched and touching. The researcher will conduct minimally-structured interviews with a set of follow-up interviews to verify interpretations and ascertain additional participant reflections on the phenomenon of touch. The purpose of this study is to describe the sensation of touch in adult oncology patients who are actively undergoing chemotherapy treatment. The primary objective is to identify the essences of multiple meanings of touch to these patients. The importance of touch in physiological development, learning patterns, and stress reduction has been demonstrated in humans and animals through years of research (Field, 2000). Based on research which indicates touch therapies provide a significant amount of symptom relief and reduction in anxiety, a growing number of hospitals and clinics are integrating massage therapy into services provided to patients in order to ameliorate many symptoms of diagnosis and/or treatment-related discomfort. Examples are the integrative medicine programs at Memorial Sloan-Kettering Cancer Center and George Washington University Medical Center which include touch therapy modalities. Research focusing on the embodied experience of sensory phenomena such as touch is important to provide the basis for more effective care. No studies to date have focused on the self-reported experience of the cancer patient with regard to what touch means to these individuals, particularly those actively in treatment with intravenous chemotherapy. The embodied sensation of touch in these people is important to understand in order to provide more effective touch-based interventions and also to increase awareness of direct care staff, including nurses, of the profound and complex effect that all forms of touch have on those who are physically and psychically vulnerable.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2007

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

February 29, 2008

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 10, 2008

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2008

Completed
Last Updated

June 17, 2009

Status Verified

June 1, 2009

Enrollment Period

1.5 years

First QC Date

February 29, 2008

Last Update Submit

June 16, 2009

Conditions

Keywords

cancerqualitative

Outcome Measures

Primary Outcomes (1)

  • The primary objective is to identify the essences of multiple meanings of touch to these patients.

    one year

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

adults, at least 18 years old, who have been diagnosed with cancer (any form) and are in active treatment. Treatment must include intravenous chemotherapy (either as an outpatient or an inpatient) with or without surgery and/or radiation. Each participant will be fluent in English, able to hear and speak, fully alert and oriented, able to verbalize both concrete and abstract ideas, and able to comprehend and sign consent for participation.

You may qualify if:

  • Adults, at least 18 years old, who have been diagnosed with cancer (any form) and are in active treatment.
  • Treatment must include intravenous chemotherapy (either as an outpatient or an inpatient) with or without surgery and/or radiation.
  • Each participant will be fluent in English, able to hear and speak, fully alert and oriented, able to verbalize both concrete and abstract ideas, and able to comprehend and sign consent for participation.

You may not qualify if:

  • Anyone else

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SUNY UMU

Syracuse, New York, 13210, United States

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Melanie Kalman, RN PhD

    SUNY UMU

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Sponsor Type
OTHER

Study Record Dates

First Submitted

February 29, 2008

First Posted

March 10, 2008

Study Start

February 1, 2007

Primary Completion

August 1, 2008

Study Completion

August 1, 2008

Last Updated

June 17, 2009

Record last verified: 2009-06

Locations